本季度信息
鹰瞳科技-B（02251.HK）公布了2026年中期业绩，报告期内实现营收约6,729.10万元，同比下降19.6%。毛利率为73.3%，上年同期为76.6%。经营活动所用现金流为-847.20万元，相比上年同期的-1,806.30万元明显收窄。
从成本结构看，销售及分销费用约2,740万元，同比上升8.3%；行政开支约1,750万元，同比下降27.4%；研发投入约3,110万元，占营收比例相对均衡，同比下降6.3%。管理层表示，研发方面主要用于“万语”医疗大模型以及各条产品线的AI算法升级与临床试验等领域。
业务分项
公司近视防控AI业务收入约2,794万元，同比上升24.0%，主要得益于本期合作门店数量和用户规模的扩大。视网膜检测AI业务收入约3,690万元，同比下降35.6%，公司称主要受代理商收款策略及信用政策调紧等因素影响。视觉训练AI业务录得210万元，同比下降46.2%。新推出的抗压能力监测AI产品实现收入约40万元。
（文中货币单位均为人民币，且已根据公告单位及换算规则进行折合。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.